نتایج جستجو برای: ps1

تعداد نتایج: 1975  

Journal: :Proceedings of the National Academy of Sciences of the United States of America 2000
W Xia W J Ray B L Ostaszewski T Rahmati W T Kimberly M S Wolfe J Zhang A M Goate D J Selkoe

An unusual intramembranous cleavage of the beta-amyloid precursor protein (APP) by gamma-secretase is the final step in the generation of amyloid beta-peptide (Abeta). Two conserved aspartates in transmembrane (TM) domains 6 and 7 of presenilin (PS) 1 are required for Abeta production by gamma-secretase. Here we report that the APP C-terminal fragments, C83 and C99, which are the direct substra...

Journal: :Journal of neurochemistry 2004
Chad A Dickey Marcia N Gordon Jerimiah E Mason Nedda J Wilson David M Diamond John F Guzowski Dave Morgan

Mice transgenic for mutated forms of the amyloid precursor protein (APP) plus presenilin-1 (PS1) genes (APP + PS1 mice) gradually develop memory deficits which correlate with the extent of amyloid deposition. The expression of several immediate-early genes (IEGs: Arc, Nur77 and Zif268) and several other plasticity-related genes (GluR1, CaMKIIalpha and Na-K- ATPase alphaIII) critical for learnin...

Journal: :The Journal of neuroscience : the official journal of the Society for Neuroscience 2007
William E Klunk Julie C Price Chester A Mathis Nicholas D Tsopelas Brian J Lopresti Scott K Ziolko Wenzhu Bi Jessica A Hoge Ann D Cohen Milos D Ikonomovic Judith A Saxton Beth E Snitz Daniel A Pollen Majaz Moonis Carol F Lippa Joan M Swearer Keith A Johnson Dorene M Rentz Alan J Fischman Howard J Aizenstein Steven T DeKosky

The amyloid cascade hypothesis suggests that the aggregation and deposition of amyloid-beta protein is an initiating event in Alzheimer's disease (AD). Using amyloid imaging technology, such as the positron emission tomography (PET) agent Pittsburgh compound-B (PiB), it is possible to explore the natural history of preclinical amyloid deposition in people at high risk for AD. With this goal in ...

Journal: :Neuron 2015
Marie-Victoire Guillot-Sestier Kevin R. Doty David Gate Javier Rodriguez Brian P. Leung Kavon Rezai-Zadeh Terrence Town

The impact of inflammation suppressor pathways on Alzheimer's disease (AD) evolution remains poorly understood. Human genetic evidence suggests involvement of the cardinal anti-inflammatory cytokine, interleukin-10 (IL10). We crossed the APP/PS1 mouse model of cerebral amyloidosis with a mouse deficient in Il10 (APP/PS1(+)Il10(-/-)). Quantitative in silico 3D modeling revealed activated Aβ phag...

Journal: :Annals of neurology 2010
Yakeel T Quiroz Andrew E Budson Kim Celone Adriana Ruiz Randall Newmark Gabriel Castrillón Francisco Lopera Chantal E Stern

OBJECTIVE The examination of individuals who carry fully penetrant genetic alterations that result in familial Alzheimer's disease (FAD) provides a unique model for studying the early presymptomatic disease stages. In AD, deficits in episodic and associative memory have been linked to structural and functional changes within the hippocampal system. This study used functional MRI (fMRI) to exami...

2012
Liam Scott Jianlin Feng Tamás Kiss Elie Needle Kevin Atchison Thomas T. Kawabe Anthony J. Milici Éva Hajós-Korcsok David Riddell Mihály Hajós

Transgenic mice are used to model increased brain amyloid(A ) and amyloid plaque formation reflecting Alzheimer’s disease athology. In our study hippocampal network oscillations, population spikes, and long-term potentiation (LTP) were recorded in APPswe/ S1dE9 (APP/PS1) and presenilin1 (PS1) transgenic and wild type mice at 2, 4, and 8 months of age under urethane anesthesia. ippocampal theta ...

2016
RUHUI LIN JIXIANG CHEN XIAOJIE LI JINGJIE MAO YUNAN WU PEIYUAN ZHUO YINZHENG ZHANG WEILIN LIU JIA HUANG JING TAO LI-DIAN CHEN

Alzheimer's disease (AD) is a common human neurodegenerative disorder characterized by progressive deterioration of cognition and memory. Acupuncture at the Baihui (DU20) acupoint has long been used in China to clinically treat cognitive impairment. However, the precise mechanism underlying its neuroprotective effects remains to be elucidated. In the present study, electroacupuncture (EA) at th...

2015
Hao Li Yun Wei Zhiyong Wang Qi Wang

Alzheimer’s disease (AD), the most common neurodegenerative disorder, will not only reduce quality of life severely, but also bring heavy economic burden to the family and society. Slow progress in AD therapies partially due to lack of appropriate animal models. APP/PS1 transgenic mouse, a widely used animal model for AD, can be used in lots of aspects for AD related study, such as neuronal apo...

Journal: :CNS neuroscience & therapeutics 2017
Yan Liu Yan-Feng Xu Ling Zhang Lan Huang Pin Yu Hua Zhu Wei Deng Chuan Qin

AIMS Alzheimer's disease (AD), a progressive development dementia, is increasingly impacting patients' living conditions worldwide. Despite medical care and funding support, there are still no highly individualized drugs and practical strategies for clinical prevention and treatment. Developmentally regulated brain protein (abbreviated as Drebrin or Dbn, also known as Dbn1 in mouse) exists in n...

2011
Paula L. McClean Vadivel Parthsarathy Emilie Faivre Christian Hölscher

Type 2 diabetes is a risk factor for Alzheimer’s disease, most likely linked to an impairment of insulin signaling in the brain. The incretin hormone glucagon-like peptide-1 (GLP-1) facilitates insulin signaling, and novel long-lasting GLP-1 analogs, such as liraglutide, are on the market as diabetes therapeutics. GLP-1 has been shown to have neuroprotective properties in vitro and in vivo. Her...

نمودار تعداد نتایج جستجو در هر سال

با کلیک روی نمودار نتایج را به سال انتشار فیلتر کنید